FIELD: organic chemistry.
SUBSTANCE: invention relates to new lipids and compositions containing them. The invention relates to a compound of formula (IA), where l represents 5; m is 7; M1 is M'; R4 is -(CH2)n Q, where Q is -N(R)R8 and n is 3; M and M' are independently selected from -C(O)O- and -OC(O)-; R8 is cyclobutenyl substituted with one or more oxo, amino, heterocycloalkyl selected from piperidinyl, morpholinyl and 4-methylpiperazin-1-yl, and mono- or dialkylamino, where mono- and dialkylamino are substituted with one C1-3 alkoxy or dialkylamino; R2 and R3 are independently C8-10 alkyl; R is H; and R' is C9-18 alkyl. The invention also relates to a nanoparticle composition for delivery of a therapeutic and/or prophylactic agent based on a compound of formula (IA).
EFFECT: new compounds and a composition based on them have been obtained, which can be used in medicine when delivering therapeutic and/or prophylactic agents to cells or organs of mammals, for example, to regulate the expression of a polypeptide, protein or gene.
28 cl, 39 dwg, 42 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOUNDS | 2018 |
|
RU2767652C2 |
NEW ALKYLATING AGENTS | 2013 |
|
RU2632206C2 |
METHOD OF PRODUCING N-ARYLPYRROLIDINES AND N-ARYLPIPERIDINES | 2013 |
|
RU2547046C1 |
NEW COMPOUNDS | 2018 |
|
RU2783078C2 |
6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS | 2005 |
|
RU2379308C2 |
BENZENE DERIVATIVE SUBSTITUTED WITH 1,2-DI(CYCLIC GROUP) | 2006 |
|
RU2407735C2 |
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
DERIVATIVES OF 3,3′-DITHIOBIS-(PROPIONIC ACID) OR THEIR STEREOISOMERS AND COMPOSITION SHOWING IMMUNOMODULATING ACTION | 1991 |
|
RU2041208C1 |
CONDENSED TRICYCLIC DERIVATIVES FOR TREATING PSYCHOTIC DISORDERS | 2005 |
|
RU2409582C2 |
INHIBITORS OF TWO SITES OF BINDING ACETYLCHOLINESTERASE FOR TREATMENT OF THE ALZHEIMER'S DISEASE | 2003 |
|
RU2325379C2 |
Authors
Dates
2023-06-21—Published
2018-03-15—Filed